DaVita Inc. (DVA)
| Market Cap | 10.83B |
| Revenue (ttm) | 12.97B |
| Net Income (ttm) | 859.61M |
| Shares Out | 75.50M |
| EPS (ttm) | 10.11 |
| PE Ratio | 14.19 |
| Forward PE | 12.81 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 734,789 |
| Open | 141.17 |
| Previous Close | 141.84 |
| Day's Range | 140.81 - 144.19 |
| 52-Week Range | 131.76 - 179.60 |
| Beta | 1.11 |
| Analysts | Hold |
| Price Target | 157.00 (+9.44%) |
| Earnings Date | Aug 5, 2025 |
About DVA
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition... [Read more]
Financial Performance
In 2024, DaVita's revenue was $12.82 billion, an increase of 5.56% compared to the previous year's $12.14 billion. Earnings were $936.34 million, an increase of 35.40%.
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for DVA stock is "Hold." The 12-month stock price target is $157.0, which is an increase of 9.44% from the latest price.
News
20 stocks primed for rapid growth while trading at half of Nvidia's valuation
When selecting investments, it is easy to get hung up on a particular metric, such as a dividend yield or a price ratio, but investors need to look deeper or they might miss opportunities.
DaVita Statement on Government's Kidney Care Choices (KCC) Model Updates
DENVER , May 30, 2025 /PRNewswire/ -- DaVita, a comprehensive kidney care company, issued the following statement in response to updates this week from the Center for Medicare and Medicaid Innovation ...
DaVita: International Expansion And Buybacks Will Boost Returns
International expansion continues with new clinics in Brazil, Ecuador, Chile, and Colombia, supporting long-term growth beyond the US market. DaVita's stock offers a 10% FCF yield, and the share count...
DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior Notes Offering
DENVER , May 20, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita") announced today the upsize and pricing of its previously announced private offering (the "offering") of its 6.750% senior notes...
DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship
Captures key initiatives achieved in 2024, driving 2025 ESG goals DENVER , May 20, 2025 /PRNewswire/ -- Today, DaVita (NYSE: DVA) published its Community Care report, underpinning its long-standing co...
DaVita Inc. Announces Offering of $750 Million Senior Notes
DENVER , May 20, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita") announced today that it has commenced a private offering (the "offering") of $750 million aggregate principal amount of its sen...
DaVita Inc. (DVA) Q1 2025 Earnings Call Transcript
DaVita Inc. (NYSE:DVA) Q1 2025 Earnings Conference Call May 12, 2025 5:00 PM ET Company Participants Nic Eliason - Group VP, IR Javier Rodriguez - CEO Joel Ackerman - CFO Conference Call Participants...
DaVita beats quarterly profit estimates amid stable demand for dialysis services
DaVita beat Wall Street estimates for first-quarter profit on Monday, driven by steady demand for its kidney dialysis services.
DaVita First-Quarter 2025 Financial Results: Just the Numbers
Kidney treatment company DaVita (DVA) on Monday afternoon reported first-quarter 2025 financial results. A summary of its key numbers is below.
DaVita Inc. 1st Quarter 2025 Results
DENVER , May 12, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2025. "Our strong first quarter performance demonstrates the sta...
DaVita Inc. Schedules 1st Quarter 2025 Investor Conference Call
DENVER , April 30, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Monday, May 12, 2025, at 5:00 p.m. ...
DaVita Says Ransomware Attack Affecting Some Operations
DaVita has been hit with a ransomware attack that has affected some of the kidney-care company's operations.
Dialysis firm DaVita hit by ransomware attack
DaVita said on Monday it had become aware of a ransomware incident that has encrypted some elements of its network, prompting the dialysis firm to implement measures to limit the effect of the breach.
DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2025
DENVER , March 6, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will pa...
YMCA of the USA Deepens Collaboration with DaVita to Drive Kidney Health Initiatives in Seven Communities
CHICAGO and DENVER, Feb. 27, 2025 (GLOBE NEWSWIRE) -- YMCA of the USA (Y-USA), the national resource office for the 2,600+ YMCAs across the country, is excited to expand its collaboration with DaVita,...
Berkshire Hathaway sells another 750,000 DaVita shares
Warren Buffett's Berkshire Hathaway said it has sold an additional 750,000 shares of DaVita , reducing its stake in the kidney dialysis services provider by about 2% to 35.14 million shares worth $5.4...
DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping.
DaVita shares were tumbling 13.5% Friday to lead S&P 500 decliners, after Warren Buffett's Berkshire Hathaway pared its stake in the provider of kidney dialysis.
Warren Buffett's Berkshire Hathaway sells some DaVita; Shares fall on disappointing guidance
DaVita shares tumbled after issuing a weak outlook amid rising care costs, while big investor Berkshire offloaded some shares in a pre-planned agreement.
DaVita Inc. (DVA) Q4 2024 Earnings Call Transcript
DaVita Inc. (NYSE:DVA) Q4 2024 Earnings Conference Call February 13, 2025 5:00 PM ET Company Participants Nic Eliason - Group VP, IR Javier Rodriguez - CEO Joel Ackerman - CFO Conference Call Partici...
Berkshire sells some DaVita shares, cuts stake to 45%
Berkshire Hathaway said on Thursday night it sold 203,091 shares of DaVita , reducing its stake in the kidney dialysis services provider to about 35.89 million shares, a 45% stake worth nearly $6.4 bi...
DaVita forecasts 2025 profit below estimates, shares plummet
Dialysis firm DaVita projected annual profit below estimates on Thursday due to rising patient care costs, sending its shares down 11% in after-hours trading.
DaVita Inc. 4th Quarter 2024 Results
DENVER , Feb. 13, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended December 31, 2024. "Despite a year with unique hurdles, we finished stron...
DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call
DENVER , Jan. 30, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 13, 2025, at 5:0...
Barclays' Andrew Mok: Any sustained underperformance in big tech will likely benefit healthcare
Andrew Mok, Barclays director of equity research, joins CNBC's 'The Exchange' to discuss why healthcare may offer opportunity as tech stocks are under pressure from China competition.